Document Detail

Primary thyroid marginal zone B-cell lymphoma MALT-type in a patient with rheumatoid arthritis.
MedLine Citation:
PMID:  19705304     Owner:  NLM     Status:  MEDLINE    
Autoimmune diseases are defined as specific, adapted immune reactions against self antigens. Immune mechanism deficiency is a causal factor for B-cell lymphoma in primary Sjögren's syndrome and autoimmune thyroid disease. Thyroid mucosa-associated lymphoid tissue (MALT) lymphoma is a 67-fold and parotid lymphoma is a 44-fold increased risk in Sjögren's syndrome and thyroiditis. MALT lymphoma was not reported in rheumatoid arthritis. We herein report the case of a 56-year-old woman with maltoma of thyroid in rheumatoid arthritis patient.
Songul Serefhanoglu; Umit Tapan; Ihsan Ertenli; Umut Kalyoncu; Aysegul Uner
Related Documents :
8213004 - Autoimmune haemolytic anaemia, sjögren's syndrome and idiopathic thrombocytopenic purp...
15168154 - Splenic marginal zone b-cell lymphoma associated with primary sjögren's syndrome.
9715014 - Using ultrasonography to diagnose sjögren's syndrome.
9690254 - Sialographic changes in sjögren's and sox syndromes.
17274584 - Mr diagnosis of transdural disc herniation causing cauda equine syndrome.
306444 - Kartagener syndrome with abnormalities of cilia.
Publication Detail:
Type:  Case Reports; Journal Article; Review     Date:  2009-08-25
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  27     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-20     Completed Date:  2010-12-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  826-32     Citation Subset:  IM    
Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Sihhiye, 06100, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Arthritis, Rheumatoid / complications*
Combined Modality Therapy
Cyclophosphamide / administration & dosage
Disease Susceptibility
Goiter, Nodular / complications
Lymphoma, B-Cell, Marginal Zone / complications*,  drug therapy,  surgery
Middle Aged
Prednisone / administration & dosage
Thyroid Neoplasms / complications*,  drug therapy,  surgery
Vincristine / administration & dosage
Reg. No./Substance:
0/Antibodies, Monoclonal, Murine-Derived; 0/rituximab; 50-18-0/Cyclophosphamide; 53-03-2/Prednisone; 57-22-7/Vincristine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Blastocyst Injection of Embryonic Stem Cells: A Simple Approach to Unveil Mechanisms of Corrections ...
Next Document:  Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients wi...